ASCO guideline emphasizes the importance of assessment for older cancer patients, and a change in mammogram recommendations reignites screening debates.

by Eric Fitzsimmons

Black men with melanoma have higher risk of dying, and CAR T-cell therapy provides hope for aggressive lymphoma.

by Marci A. Landsmann

Reducing cancer treatment to improve quality of life without lowering effectiveness, and death rates are climbing for certain cancers in Hispanic Americans.

by Kevin McLaughlin

Childhood cancer survivors have a higher risk of developing depression and anxiety, and study links polycystic ovary syndrome to higher ovarian cancer risk for postmenopausal women.

by Thomas Celona

New treatments have changed care for multiple myeloma, and as drug companies have moved away from producing generics, the U.S. runs into cancer drug shortages.

by Eric Fitzsimmons

Women diagnosed with early-stage breast cancer are more likely to live five years or longer compared with those diagnosed in earlier decades, and reports of functional limitations increase among cancer survivors.

by Marci A. Landsmann

Daily pill lowers lung cancer death rate, and FDA authorizes importing shortage-affected cancer drugs from China.

by Kevin McLaughlin

Minimally invasive surgery found to be effective for pancreatic cancer patients, and drug shortages begin to impact some cancer treatments.

by Thomas Celona

High cancer death rates in Native Hawaiian and Pacific Islander communities, and thousands of people lose Medicaid for procedural reasons.

by Eric Fitzsimmons

Cancer drugs are affected by shortages, and angiogenesis inhibitors make a comeback in combination treatments.

by Kevin McLaughlin